HARPOON THERAPEUTICS INC's ticker is HARP and the CUSIP is 41358P106. A total of 94 filers reported holding HARPOON THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $60,515 | -4.6% | 85,232 | 0.0% | 0.00% | – |
Q1 2023 | $63,430 | -48.7% | 85,232 | -50.0% | 0.00% | – |
Q4 2022 | $123,706 | +49.0% | 170,464 | +100.0% | 0.00% | – |
Q3 2022 | $83,000 | -51.7% | 85,232 | -5.2% | 0.00% | – |
Q2 2022 | $172,000 | -92.2% | 89,932 | -79.7% | 0.00% | – |
Q1 2022 | $2,203,000 | -24.1% | 443,269 | +15.3% | 0.00% | – |
Q4 2021 | $2,902,000 | -4.3% | 384,358 | +0.2% | 0.00% | – |
Q3 2021 | $3,031,000 | -83.5% | 383,724 | -71.1% | 0.00% | -100.0% |
Q2 2021 | $18,424,000 | +330.3% | 1,328,368 | +549.0% | 0.00% | – |
Q1 2021 | $4,282,000 | +50.7% | 204,667 | +19.7% | 0.00% | – |
Q4 2020 | $2,841,000 | -5.5% | 171,027 | -3.3% | 0.00% | – |
Q3 2020 | $3,006,000 | +7.2% | 176,918 | +4.8% | 0.00% | – |
Q2 2020 | $2,803,000 | +66.3% | 168,876 | +16.0% | 0.00% | – |
Q1 2020 | $1,686,000 | -8.0% | 145,608 | +17.5% | 0.00% | – |
Q4 2019 | $1,832,000 | +25.1% | 123,887 | +15.5% | 0.00% | – |
Q3 2019 | $1,465,000 | +35.5% | 107,227 | +28.9% | 0.00% | – |
Q2 2019 | $1,081,000 | – | 83,163 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,524,425 | $66,916,000 | 29.45% |
MPM BioImpact LLC | 3,898,422 | $57,658,000 | 20.43% |
New Leaf Venture Partners, L.L.C. | 2,921,405 | $43,208,000 | 9.39% |
Soleus Capital Management, L.P. | 123,200 | $1,822,000 | 1.76% |
EcoR1 Capital, LLC | 908,547 | $13,437,000 | 1.21% |
Orbimed Advisors | 2,446,409 | $36,182,000 | 0.52% |
Artal Group S.A. | 850,000 | $12,572,000 | 0.49% |
SPHERA FUNDS MANAGEMENT LTD. | 384,031 | $5,680,000 | 0.47% |
Cormorant Asset Management, LP | 649,994 | $9,613,000 | 0.38% |
Fosun International Ltd | 190,483 | $2,817,000 | 0.23% |